Literature DB >> 22146607

Truly benign multiple sclerosis is rare: let's stop fooling ourselves--yes.

Maria Pia Amato1, Emilio Portaccio.   

Abstract

Mesh：

Year:  2011        PMID： 22146607     DOI： 10.1177/1352458511431732

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  6 in total

1.  Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.

Authors:  Maxim Bester; Mariana Lazar; Maria Petracca; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2013-05-01       Impact factor: 3.181

2.  Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.

Authors:  Anne Christin Rahn; Sascha Köpke; Jürgen Kasper; Eik Vettorazzi; Ingrid Mühlhauser; Christoph Heesen
Journal:  Trials       Date:  2015-03-21       Impact factor: 2.279

Review 3.  Definition, prevalence and predictive factors of benign multiple sclerosis.

Authors:  Tatjana Reynders; Miguel D'haeseleer; Jacques De Keyser; Guy Nagels; Marie B D'hooghe
Journal:  eNeurologicalSci       Date:  2017-05-13

4.  Impairment and restrictions in possibly benign multiple sclerosis.

Authors:  Laura Melanie Schaefer; Jana Poettgen; Anja Fischer; Stefan Gold; Jan-Patrick Stellmann; Christoph Heesen
Journal:  Brain Behav       Date:  2019-03-18       Impact factor: 2.708

5.  Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.

Authors:  Cecilia Smith Simonsen; Heidi Øyen Flemmen; Line Broch; Cathrine Brunborg; Pål Berg-Hansen; Stine Marit Moen; Elisabeth Gulowsen Celius
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

6.  Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?

Authors:  Nicolò Margaritella; Laura Mendozzi; Massimo Garegnani; Raffaello Nemni; Elena Colicino; Elisabetta Gilardi; Luigi Pugnetti
Journal:  BMC Neurol       Date:  2012-08-22       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.